In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

According to a press release, the duodenal switch procedure is a type of surgery "that combines stomach reduction with ...

A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.

Researchers are using a tiny implant that goes under the skin. It’ll release a GLP-1 medication drug in 50 cats over the ...

On December 3, 2025, the Federal Trade Commission announced that it has given final approval to an order against a ...

Okava Pharmaceuticals, a San Francisco-based company, is looking to slim down household pets with a new GLP-1 implant ...

Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.